Elanco Animal Health Incorporated recognized the second annual National Parvo Awareness Day on April 22, 2025, reaffirming its commitment to increasing the availability of Canine Parvovirus Monoclonal Antibody (CPMA). Since receiving conditional approval from the USDA, CPMA has helped save thousands of puppies from the highly contagious and often-fatal disease.
Dr. Chris George, veterinarian and infectious disease expert at Elanco, highlighted that without supportive care, parvovirus has a 91% mortality rate, but in real-world usage, 93% of parvo-infected puppies treated with CPMA survived. Additionally, CPMA-treated patients spent an average of 1.87 fewer days in the hospital.
Elanco's mission is to save 1 million puppies from parvovirus by 2030, and the company is focused on increasing access to this life-saving treatment, especially in shelter environments. The ParvoTrack online tool, launched last year, empowers pet owners and veterinarians with real-time information on parvo outbreaks.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.